Oftan Dexa-Chlora

Quick links to important sections

Oftan Dexa-Chlora

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oftan Dexa-Chlora

Property Description
Active Ingredients Chloramphenicol, Dexamethasone
Form Ophthalmic Solution (Eye Drops)
Pharmacological Class Anti-infective-Corticosteroid Combination
General Purpose Managing combined bacterial presence and inflammation
Origin Synthetic

1. The Core Combination and Its Purpose

Oftan Dexa-Chlora is a prescription-only fixed-dose ophthalmic solution classified as an Anti-infective-Corticosteroid Combination. This preparation is a synthetic medicinal entity specifically formulated for topical ophthalmic administration to the eye. The product is defined by its two specific active ingredients: Chloramphenicol, a broad-spectrum antibiotic, and Dexamethasone, a potent synthetic glucocorticoid.

The combination is designed to deliver agents from two distinct pharmacological classes simultaneously. The Chloramphenicol component works by exerting a bacteriostatic effect, halting the proliferation of susceptible bacteria. Chloramphenicol provides coverage against a wide range of bacteria, including those often implicated in superficial eye infections. This means the medicine includes a reliable agent designed to stop the growth of common types of bacteria.

2. Dexamethasone and Unique Dual Action

Concurrently, the inclusion of Dexamethasone serves as a powerful anti-inflammatory agent, suppressing the processes that cause swelling, redness, and irritation in ocular tissues. As a glucocorticoid, Dexamethasone acts to mitigate inflammatory responses. Therefore, this component provides strong relief from the discomfort and damage caused by inflammation.

The overall utility of Oftan Dexa-Chlora centers on this dual-action efficiency, a key differentiating factor from monotherapy drops. It provides a synchronous approach, which is typically used when the ocular condition is suspected to involve both a microbial factor and a significant inflammatory component that requires management.

3. Ophthalmic Solution: Form and Delivery

The medication is manufactured exclusively as an Ophthalmic Solution, commonly known as sterile eye drops. This liquid dosage form is engineered for direct, topical ophthalmic delivery, which ensures both the Chloramphenicol and the Dexamethasone are applied locally to the affected tissues. The aqueous nature of the solution ensures compatibility with the eye's sensitive surface and facilitates the controlled release of the fixed-dose agents.

What side effects are possible with Oftan Dexa-Chlora?

Possible Side Effects and Safety Information

The safety profile of Oftan Dexa-Chlora, as documented in official regulatory sources, centers on ocular adverse reactions and specific risks related to duration of use and patient status.


Adverse Reactions

Side effects are categorized by frequency and the body system affected.

Frequency Common Ocular Adverse Reactions
Common Stinging, burning, eye irritation, blurred vision, eye pain, foreign body sensation, and ocular hyperemia (eye redness).
Uncommon Increased intraocular pressure (IOP), glaucoma, cataract, reduced visual acuity, corneal melting or perforation, persistent corneal defect, and eyelid swelling.
Rare Hypersensitivity reactions such as contact dermatitis and itching.

Serious Risks and Safety Limitations

  • Duration-Related Risks: Prolonged or repeated use, particularly over several weeks, significantly increases the risk of elevated Intraocular Pressure (IOP), which may lead to glaucoma and damage to vision. It also increases the risk of cataract formation.
  • Infection and Wound Healing: The steroid component (dexamethasone) can mask the signs of pre-existing bacterial, viral, or fungal infections, or potentially enhance or exacerbate certain infections. The drug is contraindicated (should not be used) in the presence of specific untreated acute bacterial, viral (including Herpes Simplex keratitis), and fungal eye diseases. It may also inhibit the healing of eye wounds.
  • Population Restrictions: The drug is generally not recommended for use in children and adolescents. It is also typically contraindicated during pregnancy and breastfeeding due to the potential for systemic absorption of the steroid, which has been associated with teratogenic effects in animal studies.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory guidance for Oftan Dexa-Chlora (Chloramphenicol/Dexamethasone ophthalmic solution) overdose focuses on managing local effects and defining clear triggers for seeking assistance. Regulatory documents state that the likelihood of systemic toxicity following accidental ingestion of the drops is unlikely due to the low content of the antibiotic active substance.

Documented Overdose Manifestations

Exposure Type Documented Manifestations Mandatory Immediate Action
Ocular Over-application Transient irritation, pain, swelling, lacrimation, and photophobia (light sensitivity). Irrigation of the exposed eye(s) with copious amounts of room temperature water for at least 15 minutes.
Accidental Ingestion Systemic effects are unlikely. Measures should be taken to delay and reduce the extent of absorption of active substances.

Requirements for Seeking Emergency Help

Emergency medical assistance is officially required based on the persistence of symptoms. An ophthalmological examination should be considered if the local ocular symptoms (pain, irritation, swelling) persist after the mandatory 15-minute irrigation procedure. For guidance on accidental ingestion, official advice mandates contacting the National Poisons Information Centre. It is documented that no specific antidote is known for this product's overdose. Treatment remains symptomatic and supportive.

Therapeutic Uses of Oftan Dexa-Chlora

Main Uses and Benefits of Oftan Dexa-Chlora

Oftan Dexa-Chlora is a combination ophthalmic medication designed to treat inflammatory conditions of the eye where a secondary bacterial infection is present or where there is a significant risk of such an infection occurring. It combines the properties of a corticosteroid and an antibiotic to provide a dual-action approach to ocular health.

Treatment of Ocular Inflammation

The primary therapeutic role of the medication is to manage non-infectious inflammatory processes affecting the anterior segment of the eye. This includes conditions such as:

  • Iritis and Iridocyclitis: Inflammation of the iris and the surrounding ciliary body.
  • Uveitis: Inflammation of the middle layer of the eye.
  • Conjunctivitis: Allergic or non-purulent inflammation of the conjunctiva when accompanied by bacterial risk.
  • Keratitis: Inflammation of the cornea.
  • Post-operative Recovery: Management of inflammation following ophthalmic surgery.

Prevention and Control of Bacterial Infection

While the steroid component addresses swelling, redness, and irritation, the antimicrobial component is included to treat or prevent infections caused by susceptible microorganisms. This is particularly relevant in cases where the eye's natural defenses are compromised by inflammation or surgical trauma.

Benefits of Combination Therapy

Using a combined formulation offers several clinical advantages for the management of complex eye conditions:

  • Reduction of Tissue Damage: By controlling intense inflammation, the medication helps prevent potential scarring or long-term damage to delicate ocular structures.
  • Symptomatic Relief: The treatment helps alleviate common symptoms associated with ocular distress, such as pain, burning, and the sensation of a foreign body in the eye.
  • Broad-Spectrum Coverage: The antibiotic component is effective against a wide range of Gram-positive and Gram-negative bacteria commonly found in external eye infections.

Eligibility and Restrictions for Use

The eligibility profile for Oftan Dexa-Chlora is strictly defined by official regulatory documents, focusing on absolute contraindications and population restrictions.

Contraindicated Populations and Conditions

  • Hypersensitivity: Patients with known sensitivities to Chloramphenicol, Dexamethasone, or any excipients must not use the medicine.
  • Blood Disorders: Individuals with a personal or family history of blood dyscrasias, including aplastic anaemia or myelosuppression from previous exposure, are prohibited from use.
  • Age: The medicine is strictly contraindicated for neonates (infants under 28 days of age).
  • Ocular Infection Type: Use is prohibited in the presence of ocular infections caused by viruses (such as herpetic epithelial keratitis), fungi, or tuberculous agents.
  • Comorbidity: The medicine is contraindicated for patients diagnosed with glaucoma or hepatic dysfunction.

Age and Life Stage Restrictions

  • Use during pregnancy is not recommended, and use during lactation/breastfeeding is formally contraindicated.
  • Long-term administration to children is prohibited, and use in children under two years is strictly restricted to exceptional cases.

These regulatory rules ensure the medicine is used only for short-term, specific conditions where the risk profile meets regulatory criteria, prohibiting use in sensitive life stages and specific pre-existing conditions.

What should I know about interactions with other medicines?

The documented interaction profile for Oftan Dexa-Chlora involves both pharmacokinetic (PK) and pharmacodynamic (PD) mechanisms, as outlined in official regulatory documents.

Exposure Modification: Co-administration with potent CYP3A4 inhibitors may lead to increased systemic exposure of the Dexamethasone component. This PK interaction is officially noted for its potential to raise the risk of systemic corticosteroid effects. Separately, the Chloramphenicol component acts as an enzyme inhibitor, which is documented to increase the plasma concentrations of certain co-administered systemic drugs, including Phenytoin and Dicumarol (or related coumarin anticoagulants).

Topical and Procedural Constraints: A significant pharmacodynamic risk involves the concurrent use of the corticosteroid component with Ophthalmic Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This combination can result in an additive effect that may increase the potential for corneal healing problems. A necessary procedural constraint requires a time separation between the application of this solution and all other topical ophthalmic preparations to prevent the interaction of physical washout.

Restrictions and Special Populations: The official profile lists restrictions and is formally contraindicated for use in ocular conditions caused by viral, fungal, or mycobacterial agents. Special caution is noted for patients with impaired hepatic or renal function, as regulatory documents specify an increased risk of drug accumulation of the Chloramphenicol component due to reduced systemic clearance.

Mechanism of Action

How Oftan Dexa-Chlora Works


Mechanism of Microbial Protein Synthesis Inhibition

The chloramphenicol component acts as a direct inhibitor by targeting and binding to the bacterial 50S ribosomal subunit . This interaction blocks the peptidyl transferase enzyme, halting peptide bond formation and subsequent protein chain elongation. This mechanistic cascade results in the limitation of microbial proliferation by preventing the creation of essential microbial structural and functional proteins.


️ Modulation of Inflammatory Gene Expression

The dexamethasone component acts as an agonist by binding to the intracellular Glucocorticoid Receptor (GR). The activated GR complex translocates to the nucleus, where it modulates gene transcription. This action suppresses the expression of genes responsible for producing key pro-inflammatory signaling molecules, such as certain cytokines and enzymes involved in the inflammatory pathway. This mechanism results in the suppression of pro-inflammatory mediator synthesis, thereby modulating the associated vascular permeability and tissue response.


Dual Physiological Influence

The two distinct mechanistic domains operate in parallel, influencing two separate physiological axes. One component exerts a direct influence on the microbial growth process, while the other controls the intensity of the associated inflammatory signaling cascade. This parallel pharmacodynamic action results in a dual influence on microbial load and the local tissue response.

Dosage and Administration Information

Administration Guidelines for Oftan Dexa-Chlora

The usage of this product is governed by official instructions detailing the specific route, dosing schedule, and handling procedures to ensure its correct administration. The medicine must be used as a short-term, high-frequency topical ocular regimen that demands adherence to a specific titration pattern.

Usage Protocol (Dosing and Route)

Feature Official Labeled Instruction
Route of administration Topical Ophthalmic Use (Instillation into the conjunctival sac of the eye).
Standard Dosing One drop per affected eye, typically instilled 3 to 5 times daily.
Severe Case Schedule May be temporarily increased to one drop every hour for the first 24 to 48 hours.
Course Duration Total duration should generally not exceed 10 days.

Special Procedural Conditions

The official regimen mandates that the initial high frequency must be gradually decreased (tapered) as the condition subsides. To reduce systemic absorption, the technique of nasolacrimal occlusion (gently pressing the inner corner of the eye) is advised for 2 to 3 minutes following instillation. Users must remove soft contact lenses prior to application, and re-insertion should occur after at least 15 minutes. For newborn infants and children, special caution and potential dosage adjustment are required when administering this combination product.

Recent Clinical Evidence

Oftan Dexa-Chlora: Recent Clinical Evidence

Clinical evidence for the fixed-dose combination of dexamethasone (a corticosteroid) and chloramphenicol (an antibiotic) focuses primarily on its use in steroid-responsive inflammatory ocular conditions where a bacterial infection or the risk of one exists. The rationale for this combination is to address both inflammation and potential infection simultaneously.


Studies on Inflammatory Ocular Conditions

Randomized controlled trials (RCTs) have investigated the combination's application in managing inflammation following ophthalmic surgery, such as cataract extraction. Research has explored the effectiveness of the combination in reducing anterior chamber inflammation and controlling common post-operative signs, which often include redness and swelling.

In studies focusing on post-operative care, the combination was evaluated for its ability to reduce inflammation and prevent bacterial proliferation. Clinical data has noted the components' roles: dexamethasone's anti-inflammatory properties and chloramphenicol's broad-spectrum antibacterial activity.


Functional and Safety Assessment

Research has explored whether this combination affects patient-reported outcomes (PROs), such as discomfort, pain, and photophobia, by evaluating symptom reduction over short treatment periods. However, the efficacy findings related to complex or severe ocular infections are limited.

Safety assessments in clinical use emphasize the potential risks associated with the long-term use of topical ophthalmic corticosteroids, including the possibility of increased intraocular pressure (IOP) and, less commonly, the development of posterior subcapsular cataracts. Given chloramphenicol's profile, regulatory guidelines stress that treatment duration should be limited to the shortest time necessary to manage the condition.

Frequently Asked Questions (FAQ)

Common questions about Oftan Dexa-Chlora (FAQ)


Q: Can Oftan Dexa-Chlora cause blurry vision after I put it in?

Yes, official product information lists blurred vision as a common adverse reaction. It is often transient, meaning it may only last for a short time after you apply the drops. These disturbances may temporarily affect the ability to drive or operate machinery, and caution is advised.


Q: Is it normal to feel a sting when using Oftan Dexa-Chlora?

Official regulatory documents list stinging and burning sensations in the eye as common ocular adverse reactions to the medication. Official product information notes that these sensations are common ocular adverse reactions.


Q: Are there special instructions for pregnant or breastfeeding women regarding Oftan Dexa-Chlora?

Regulatory warnings indicate that use during pregnancy is generally advised against. Furthermore, use of this medication is formally contraindicated (prohibited) during lactation or breastfeeding due to the potential for systemic absorption of the steroid component.


Q: Is it true that Oftan Dexa-Chlora might increase eye pressure?

Yes, regulatory documents warn that prolonged or repeated use of the corticosteroid component (dexamethasone) significantly increases the risk of elevated Intraocular Pressure (IOP). This risk emphasizes why monitoring of Intraocular Pressure (IOP) is required during prolonged treatment.


Q: Does Oftan Dexa-Chlora have any research backing its use for post-operative care?

Yes, official summaries of clinical data indicate that the combination has been investigated in controlled trials for managing inflammation following ophthalmic surgery, such as cataract extraction. This research explores its effectiveness in reducing inflammation and preventing potential bacterial growth after these procedures.


Q: Why is shaking the bottle of Oftan Dexa-Chlora sometimes necessary?

Although the formulation is listed as a solution, some combination drops are suspensions. If the product is a suspension, official instructions usually advise shaking the bottle to ensure the active ingredients are fully mixed and delivered correctly.


Q: What are the signs that Oftan Dexa-Chlora is not working for my infection?

Official warnings advise that if there is no noticeable improvement after a short initial period of use, the treatment should be re-evaluated. The steroid component can potentially mask or enhance signs of a worsening infection, which is why close observation by a healthcare professional is important.


Q: What kind of research has been done on the combination of dexamethasone and chloramphenicol in eye drops?

Clinical studies supporting this combination focus on its use in inflammatory conditions of the eye where the presence or risk of a bacterial infection exists. This includes trials related to reducing inflammation after surgery and managing common inflammatory symptoms.


Q: Does using Oftan Dexa-Chlora affect the results of an eye exam?

Regulatory guidance indicates that patients on treatment for longer than 10 days require regular monitoring of Intraocular Pressure (IOP). This necessity for monitoring means that the potential effects of the medication are a key consideration during eye examinations.


Q: What happens if I miss a dose of Oftan Dexa-Chlora?

Official patient information often suggests that if a dose is missed, it should generally be skipped if the next application time is approaching, and a double dose should not be used to compensate.


Q: Can children use Oftan Dexa-Chlora?

This medicine has strict limitations for use in children. It is formally prohibited (contraindicated) for infants under 28 days of age. Long-term administration is prohibited for children and adolescents, and use in children under two years is strictly restricted to exceptional circumstances.


Q: Can Oftan Dexa-Chlora be used for pink eye?

The official indication is for steroid-responsive inflammatory ocular conditions where a bacterial infection is present or suspected. This generally covers bacterial conjunctivitis, which is a common form of 'pink eye'.


Q: What's the difference between Oftan Dexa-Chlora and just a regular antibiotic eye drop?

The primary difference is that Oftan Dexa-Chlora is a combination product. It includes an anti-infective agent (chloramphenicol) to target bacteria and a potent anti-inflammatory corticosteroid (dexamethasone) to suppress related swelling, redness, and irritation.


Q: Are there any long-term effects of using Oftan Dexa-Chlora repeatedly?

Regulatory documents state that using the medication for prolonged periods or repeatedly increases the risk of serious side effects. These risks include the possibility of developing elevated eye pressure, which is a risk factor for glaucoma, and the formation of cataracts.


Q: Does Oftan Dexa-Chlora come as an ointment or just as drops?

Official information specifies that Oftan Dexa-Chlora is manufactured exclusively as an ophthalmic solution, which means it is in the form of sterile eye drops.


Q: How do doctors monitor a patient while they are on Oftan Dexa-Chlora?

For patients using the medication for longer than 10 days, regulatory warnings specify that doctors should regularly monitor Intraocular Pressure (IOP). This monitoring is an important safety measure designed to help mitigate the risk of developing steroid-induced glaucoma.


Q: Can Oftan Dexa-Chlora affect driving or operating machinery?

Official product information states that the medicine may cause transient blurred vision or other temporary visual disturbances. If visual disturbances occur, caution is recommended, and activities requiring clear vision should be avoided until the visual impairment resolves.


Q: How does Oftan Dexa-Chlora compare to eye drops that only contain an antibiotic?

Oftan Dexa-Chlora provides dual action: treating the bacterial component and aggressively controlling inflammation. Simple antibiotic-only drops focus solely on the microbial factor, while the combination is used when both infection and significant inflammation require treatment.


Q: Can Oftan Dexa-Chlora be used for ear infections?

No. The official labeled instructions specify the route of administration as Topical Ophthalmic Use only. The formulation is intended solely for instillation into the conjunctival sac of the eye.


Q: What are the signs of a serious side effect from Oftan Dexa-Chlora?

Serious potential risks listed in regulatory documents include signs of increased eye pressure, which may present as changes in vision or discomfort, or the long-term risk of cataract formation. There are also warnings concerning the potential for corneal defects or perforation.


Q: Is it possible to become resistant to Oftan Dexa-Chlora over time?

Official warnings advise that prolonged use of anti-bacterial agents may lead to the overgrowth of non-susceptible organisms, which is a risk factor for treatment resistance.


Q: Does Oftan Dexa-Chlora contain any preservatives?

Regulatory documentation, specifically the list of excipients, typically details all non-active ingredients, including any preservatives. These components are necessary for maintaining the solution's sterility and stability over its shelf life.


Q: Can Oftan Dexa-Chlora be used with artificial tears?

Yes, it can be used with other topical eye medications, but official instructions mandate a time separation between applications. This is necessary to minimize the physical washout of the active ingredients and ensure proper drug delivery.


Q: What should I do if the Oftan Dexa-Chlora drops look cloudy?

Regulatory guidance implies that a solution should appear clear. If the drops look cloudy or show any change in appearance, it may indicate contamination or product degradation. Official guidance recommends proper disposal of the solution if its appearance is compromised.


Q: Is Oftan Dexa-Chlora effective against fungal eye infections?

No. The medication is formally prohibited (contraindicated) for use in ocular conditions known or suspected to be caused by fungal agents. The steroid component may even mask or worsen a pre-existing fungal infection.


Q: Are there certain vitamins or supplements that interact with Oftan Dexa-Chlora?

Official interaction documents list drug-drug interactions, particularly involving substances that affect the CYP3A4 metabolic pathway. This is the mechanism by which the steroid component is processed, indicating a potential for interaction with supplements that also influence this pathway.


Q: Why is it important not to share Oftan Dexa-Chlora with others?

As a prescription-only medication for specific conditions, it is intended only for the individual patient to prevent the potential spread of infection or inappropriate use for a different condition.


Q: Can Oftan Dexa-Chlora be used for non-infectious eye inflammation?

The medicine is specifically indicated for steroid-responsive inflammatory conditions where a bacterial infection or the risk of one exists. This suggests its use is intended only when an anti-infective component is deemed necessary.


Q: Can Oftan Dexa-Chlora be used with other topical eye medications?

Yes, it can be used with other topical eye medications, but official instructions require a time separation between applications. This is done to prevent the first medication from being washed out by the second, ensuring proper absorption.

How should Oftan Dexa-Chlora be stored and disposed of?

The official regulatory profile for Oftan Dexa-Chlora strictly defines storage, stability, and disposal requirements to ensure product quality.

Storage

  • The medicine must be stored at a temperature below 25^circC and protected from light.
  • It is mandatory not to refrigerate and not to freeze the ophthalmic solution.
  • The bottle must be kept tightly closed in its original container and out of the sight and reach of children.
  • The solution must be discarded 28 days after the bottle is first opened.

Disposal

  • Unused or expired solution must not be thrown away via wastewater (such as flushing down the sink) or household trash.
  • Disposal must be done according to local regulations for unused medicinal products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oftan Dexa-Chlora found in:

A-Z Index: